Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China flag China · Delayed Price · Currency is CNY
17.64
-0.33 (-1.84%)
At close: Sep 10, 2026

SHE:301246 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
365.09472.74745.59421.86395.19120.43
Short-Term Investments
-258.4379.25292.3190-
Trading Asset Securities
1,1961,128900.321,466--
Cash & Short-Term Investments
1,5611,8592,0252,180485.19120.43
Cash Growth
-23.99%-8.19%-7.10%349.31%302.89%-55.02%
Accounts Receivable
897.15904.42559.44602.64660.21458.16
Other Receivables
58.8646.779.89141.6787.645.85
Receivables
956.01951.12639.33744.3747.8504.01
Inventory
347.86319.01270.53191.51352.95384.48
Prepaid Expenses
-0.230.05---
Other Current Assets
462.61167.23111.2986.4378.9820.72
Total Current Assets
3,3283,2973,0463,2021,6651,030
Property, Plant & Equipment
2,5122,3642,2921,9101,620891.27
Long-Term Investments
211.05211.24203.64228.08335.12242.35
Other Intangible Assets
176.11178.84181.89183.06173.62194.15
Long-Term Deferred Tax Assets
19.3719.6617.2617.5621.2217.72
Long-Term Deferred Charges
3.244.085.525.956.8611.98
Other Long-Term Assets
159.7689.5978.06103.953.2745.14
Total Assets
6,4106,1655,8255,6513,8752,432

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
836.63798.99777.27636.79934.95340.92
Accrued Expenses
14.5463.6455.2857.5465.757.98
Short-Term Debt
91.360.0459.32-17.6420.1
Current Portion of Long-Term Debt
109.6695.8277.0165.966.092.84
Current Portion of Leases
-0.750.740.60.560.53
Current Income Taxes Payable
10.7223.073.561.1538.2945.65
Current Unearned Revenue
13.7319.7913.8719.831.0129.66
Other Current Liabilities
187.29179.11148.94133.04165.66120.05
Total Current Liabilities
1,2641,2411,136914.831,320617.73
Long-Term Debt
449.64368.34230.36276.12341.6747.22
Long-Term Leases
6.236.427.166.98.198.23
Long-Term Unearned Revenue
65.4168.0868.6471.5570.4560.8
Long-Term Deferred Tax Liabilities
21.1821.7321.6221.5421.3120.3
Total Liabilities
1,8061,7061,4641,2911,762754.27

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
400.01400.01400.01400.01352.75352.75
Additional Paid-In Capital
2,1852,1772,1722,17222.1520.62
Retained Earnings
2,0611,9251,8181,7861,7391,304
Treasury Stock
-47.15-47.15-32.8---
Comprehensive Income & Other
5.874.973.371.8900.46
Total Common Equity
4,6054,4604,3614,3602,1141,678
Minority Interest
-1.48-0.730.47---
Shareholders' Equity
4,6034,4594,3614,3602,1141,678
Total Liabilities & Equity
6,4106,1655,8255,6513,8752,432

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
656.83531.36374.59349.51434.1478.92
Net Cash (Debt)
904.311,3281,6511,83151.0541.51
Net Cash Growth
-36.46%-19.55%-9.83%3485.91%22.99%-62.14%
Net Cash Per Share
2.283.354.144.720.140.12
Filing Date Shares Outstanding
396.91396.81396.81399.9400.01352.75
Total Common Shares Outstanding
396.91396.81397.89400.01352.75352.75
Working Capital
2,0642,0561,9102,287345.02411.91
Book Value Per Share
11.6011.2410.9610.905.994.76
Tangible Book Value
4,4294,2814,1794,1771,9401,484
Tangible Book Value Per Share
11.1610.7910.5010.445.504.21
Buildings
-883.32833.02719.62395.96329.31
Machinery
-1,8341,6491,470782.58657
Construction In Progress
-598.72630.57375.86946.39334.11